For distribution outside the U.S. only

Azzalure also marketed as Dysport outside of the EU for the treatment of glabellar lines marks 10 year anniversary with more than 40 million treatments in the EU and US combined and approval in 72 countries.

Solna, April 23rd 2018 - Today the Nordic affiliates of Janssen and Galderma announced their long-term partnership for the marketing of TREMFYA® (guselkumab) for the treatment of moderate to severe plaque psoriasis.

Galderma will present the latest updates from across its broad injectable aesthetics portfolio at the 2026 Aesthetic & Anti-Aging Medicine World (AMWC) congress, taking place from October 21 – 23 in Dubai, United Arab Emirates.

• Maria Teresa “Tessa” Hilado will join Galderma’s Advisory Committee on January 1, 2022 

• Alchemee’s flagship brand Proactiv® is an iconic product synonymous with acne care